February 26, 2018 – Commonly used ICU risk scores can be "repurposed" as continuous markers of severity of illness in critically ill patients—providing ongoing updates on changes in the patient's condition and risk of death, according to a study in the March issue of Critical Care Medicine, official journal of the Society of Critical Care Medicine (SCCM). The journal is published by Wolters Kluwer.
Three ICU risk scores, designed for different purposes, "performed reasonably well as a marker of severity of illness at admission, as well as throughout the ICU stay, demonstrating that it is possible for risk models to perform well even when deployed for uses other than originally intended," write Omar Badawi, PharmD, MPH, FCCM, and colleagues of Philips Healthcare, Baltimore. The study illustrates how the use of "Big Data" can advance our understanding of critically ill patients, drawing on extensive data contributed by tele-ICU programs across the United States.
One of Three ICU Risk Models Performs Best in Predicting Mortality
The study used data from the Philips eICU Research Institute database, which assembles clinical data from a diverse mix of hospitals using tele-ICU software. The analysis included de-identified data on more than 560,000 ICU patient stays, contributed by 333 ICUs at 208 US hospitals. The data covered nearly 39 million patient-hours of ICU care.
The analysis transformed three widely used ICU risk scores—designed to be assessed for different clinical scenarios—into continuous risk markers:
Hourly values for all three scores were evaluated as predictors of mortality risk. Overall, 4.8 percent of patients died in the ICU.
As continuous markers, all three models showed good accuracy in predicting the risk of death in the ICU, as well as risk of death within 24 hours. Of the three scores, the DRS had the highest predictive value. For patients in the highest ten percent of risk based on average score, the percentage who died was 30.4 percent with APACHE (average score > 80.0), 26.5 percent with SOFA (average score >7.6), and 36.4 percent with DRS (average score >13.0). The results were similar on analysis of hospitals with larger numbers of patients and deaths.
Looking closely at trends in each score during the ICU stay provided insights into the differences between the three models. Even in survivors, APACHE and SOFA scores tended to increase throughout the first 24 hours in the ICU. In contrast, the DRS decreased during the first 24 hours for survivors. That suggests that the DRS was more responsive to changes in patient condition—especially improvements.
The authors hypothesize that these differences may be attributed to model design. Both APACHE and SOFA primarily rely on the "worst" values of the preceding 24 hours to calculate a score. In contrast, DRS relies primarily on summary measures of the preceding 24 hours, such as averages and coefficient of variation.
Those observations highlight the need to be aware of differences in model design, and how the predictions may vary across ICU settings and in patients with varying characteristics. To help ICU clinicians understand these differences, Dr. Badawi and colleagues have created an online interactive data visualization tool.
"These findings suggest that it is possible to repurpose risk models for use outside of their original design, but with caveats," Dr. Badawi and coauthors conclude. They emphasize the need for further studies to determine the clinical relevance of continuous severity of illness indicators, and the need for caution when introducing these models in differing ICU settings. Dr. Badawi added, "Risk models provide objective data regarding patient status but users must combine their clinical judgment with an understanding of the model design in order to interpret the score for specific patients."
Note to editors: For further information, contact Curtis Powell, Director of Marketing and Communications for SCCM: phone +1 (847) 827-7282 or +1 (312) 285-6551; or email email@example.com.
About the Society of Critical Care Medicine
The Society of Critical Care Medicine (SCCM) is the largest nonprofit medical organization dedicated to promoting excellence and consistency in the practice of critical care. With members in more than 100 countries, SCCM is the only organization that represents all professional components of the critical care team. The Society offers a variety of activities that ensures excellence in patient care, education, research and advocacy. SCCM’s mission is to secure the highest quality care for all critically ill and injured patients. Visit www.sccm.org for more information. Follow @SCCM or visit us on Facebook.
About Critical Care Medicine
Critical Care Medicine is the premier peer-reviewed, scientific publication in critical care medicine. Directed to those specialists who treat patients in the intensive care unit and critical care unit, including chest physicians, surgeons, pediatricians, pharmacists/pharmacologists, anesthesiologists, critical care nurses and other healthcare professionals, Critical Care Medicine covers all aspects of acute and emergency care for the critically ill or injured patient. Each issue presents critical care practitioners with clinical breakthroughs that lead to better patient care, the latest news on promising research and advances in equipment and techniques. Follow @CritCare Med.
About Wolters Kluwer
Wolters Kluwer N.V. (AEX: WKL) is a global leader in information services and solutions for professionals in the health, tax and accounting, risk and compliance, finance and legal sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with specialized technology and services.
Wolters Kluwer reported 2016 annual revenues of €4.3 billion. The company, headquartered in Alphen aan den Rijn, the Netherlands, serves customers in over 180 countries, maintains operations in over 40 countries and employs 19,000 people worldwide.
Wolters Kluwer Health is a leading global provider of information and point of care solutions for the healthcare industry. For more information about our products and the organization, visit http://www.wolterskluwer.com/, follow @WKHealth or @Wolters_Kluwer on Twitter, like us on Facebook, follow us on LinkedIn, or follow WoltersKluwerComms on YouTube.